Assessment of lymphoma involvement in bone marrow by a novel cell-based liquid biopsy platform from blood sampling

Siriraj Hospital Mahidol University0 sites176 target enrollmentSeptember 21, 2022

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: ewly diagnosed lymphoma of any subtypes aged greater than 18 years.
Sponsor: Siriraj Hospital Mahidol University
Enrollment: 176
Status: Recruiting
Last Updated: last year

No summary available.

Registry

who.int

Start Date

September 21, 2022

End Date

January 1, 2024

Last Updated

last year

Study Type

Observational

Sex

All

Sponsor

Siriraj Hospital Mahidol University

•1\. Newly diagnosed lymphoma of any subtypes
•2\. Aged greater than 18 years
•3\. Participants with normal white blood cell (WBC) counts and normal differential WBC counts from the last CBC result (within 1 year)

•1\. Participants with known underlying diseases of hemolytic anemia
•2\. Participants with known underlying diseases of hematologic malignancy besides lymphoma
•3\. Participants with known underlying disease of neoplasms involving bone marrow
•4\. Participants with lymphocytosis (absolute lymphocyte count \> 4,000/mcL)
•5\. Participants with a history of recently receiving blood transfusion within 4 weeks
•6\. Participants with a history of receiving chemotherapy within 4 weeks
•7\. Participants with a history of blood donation or recent blood loss greater than 250 mL within 4 weeks
•8\. Participants who receiving erythropoietin
•9\. Participants with GI mucosal involvement of lymphoma